Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
MMSI Merit Medical Systems
72.000
+1.870+2.67%
Post Mkt Price
72.0000.0000.00%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Total revenue
7.55% 287.18M 5.23% 294.98M 10.65% 275.42M 11.50% 1.07B
Operating revenue
7.55% 287.18M 5.23% 294.98M 10.65% 275.42M 11.50% 1.07B
Cost of revenue
8.24% 158.6M 2.38% 159.91M 12.76% 154.51M 4.75% 589.42M
Gross profit
6.70% 128.57M 8.80% 135.07M 8.05% 120.91M 20.98% 485.33M
Operating expense
5.37% 109M -4.77% 103.95M 4.22% 101.4M 14.55% 406.94M
Selling and administrative expenses
3.82% 89.78M -6.64% 85.49M 3.69% 84.02M 12.75% 335.69M
Research and development costs
13.24% 19.22M 4.96% 18.47M 6.84% 17.39M 23.83% 71.25M
Operating profit
14.82% 19.57M 107.66% 31.11M 33.63% 19.51M 70.74% 78.4M
Net non-operating interest income expense
-51.90% -1.72M 3.25% -1.25M 15.68% -898K 52.16% -4.49M
Non-operating interest income
11.54% 116K 4.35% 96K -77.97% 104K 27.32% 769K
Non-operating interest expense
48.50% 1.83M -2.74% 1.35M -34.81% 1M -47.36% 5.26M
Other net income (expense)
85.34% -255K -34.25% -9.16M -429.99% -4.44M 59.83% -19.99M
Special income (charges)
17.94% -915K -29.07% -7.86M -962.69% -4.27M 63.18% -17.48M
-Less:Restructuring and merger&acquisition
-17.94% 915K -34.24% 1.19M 546.77% 2.6M 139.71% 3.16M
-Less:Impairment of capital assets
-- 0 -- 0 -- 1.67M -88.27% 4.28M
-Less:Other special charges
-- -- -- 6.67M -- -- -46.99% 10.04M
Other non- operating income (expenses)
205.60% 660K -77.04% -1.3M 62.30% -164K -10.00% -2.51M
Income before tax
24.16% 17.6M 201.54% 20.7M 11.64% 14.17M 507.51% 53.92M
Income tax
5.43% 2.33M 177.22% 5.4M 108.87% 3.63M 261.25% 5.46M
Net income
27.62% 15.27M 211.19% 15.3M -3.77% 10.55M 592.27% 48.45M
Net income continuous Operations
27.62% 15.27M 211.19% 15.3M -3.77% 10.55M 592.27% 48.45M
Minority interest income
Net income attributable to the parent company
27.62% 15.27M 211.19% 15.3M -3.77% 10.55M 592.27% 48.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.62% 15.27M 211.19% 15.3M -3.77% 10.55M 592.27% 48.45M
Basic earnings per share
28.57% 0.27 200.00% 0.27 -5.00% 0.19 577.78% 0.86
Diluted earnings per share
28.57% 0.27 200.00% 0.27 -5.26% 0.18 566.67% 0.84
Dividend per share
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
------Unqualified Opinion

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
CEO: Mr. Fred P. Lampropoulos
Market: NASDAQ
Listing Date: 02/01/1990
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist